Drug intelligence / Profile preview

Syaloset Plus

Development stage
Unknown
Lead developer
RiverPharma
Administration
Intraarticular
01

Overview

Syaloset Plus is a medical device developed by RiverPharma that serves as a synovial fluid substitute for patients with degenerative or mechanical arthropathy. The active ingredient is high molecular weight hyaluronic acid sodium salt (1.5% concentration, >2000 kDa) obtained through bacterial fermentation. This sterile, apyrogenic, viscoelastic solution is administered via intra-articular injection directly into affected joints. The mechanism of action involves restoring the viscoelastic properties of synovial fluid, which becomes degraded in traumatic and degenerative joint diseases, thereby providing pain relief and improving joint mobility. Syaloset Plus is supplied as a 4 ml pre-filled syringe and is marketed as a one-shot therapy, though additional treatments may be administered based on individual patient needs. The product must be administered exclusively by medical specialists and is indicated for treating arthropathy affecting various joints including the knee and hip.

Brand names
Syaloset Plus
Other names
Syaloset PLUS
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Syaloset Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syaloset Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call